跳至主要内容
临床试验/IRCT20230215057423N1
IRCT20230215057423N1招募中3 期

Survey the effect of topical heparin gel on the improvement of hand and foot syndrome in cancer patients treated with capecitabine

Shahre-kord University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Newly diagnosed cancer patients for gastrointestinal tract and head and neck cancer treated with capecitabine and have evidence of early onset of hand-foot syndrome (grade 1 from onset)

排除标准

  • The patient already has a skin or inflammatory disease
  • The patient's unwillingness to start the trial

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验